20 February 2025
Marlowe plc
Result of General Meeting
Marlowe plc ("Marlowe", the "Company" or the "Group"), the leader in business-critical services, announces that, at the General Meeting held today, the special resolution to provide additional authority to make market purchases of the Company's own ordinary shares was duly passed by shareholders.
The number of votes cast were as follows:
| Resolution | For | % | Against | % | Total votes cast | Withheld* |
| To authorise the Group to make market purchases of its own shares | 50,504,707 | 98.80 | 611,840 | 1.20 | 51,116,547 | 563 |
*A vote "Withheld" is not a vote in law and is not counted in the calculation of the proportion of the votes "For" or "Against" the Resolution.
As documented in the Circular dated 5 February 2025, the purpose of seeking the additional authority is to enable to Company to conclude the share buyback programme announced on 24 May 2024, and also to provide the board with flexibility in future capital allocation beyond this programme.
Capitalised terms used but not defined in this announcement have the same meetings as set out in the Circular to Shareholders dated 5 February 2025.
|
For further information: | |
|
|
|
|
Marlowe plc | |
| Lord Ashcroft, Interim Non-Executive Chair Adam Councell, Chief Financial Officer Benjamin Tucker, Head of Group Reporting
| www.marloweplc.com Tel: +44 (0)20 3813 8498
|
| Cavendish Capital Markets Limited (Nominated Adviser & Broker) | |
| Ben Jeynes George Lawson | Tel: +44 (0)20 7220 0500 |
| | |
| FTI Consulting | |
| Nick Hasell Alex Le May | Tel: +44 (0)20 3727 1340 |
About Marlowe plc
Marlowe is a leader in business-critical services which ensures compliance with strict regulations and insurance requirements across Fire Safety & Security and Water & Air Hygiene. The Group has a national footprint and serves approximately 27,000 customers across office complexes, high streets & leisure facilities, manufacturing plants and industrial estates, and include thousands of SMEs, local authorities, facilities management providers, multi-site NHS trusts and FTSE 100 companies.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.